FDA expands approval of breast cancer drug Kisqali: What to know
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of thousands of people. NBC News medical contributor Dr. Natalie Azar joins TODAY to break down what you need to know.
The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of thousands of people. NBC News medical contributor Dr. Natalie Azar joins TODAY to break down what you need to know.
What's Your Reaction?
.gif)
